Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Public ClinicalTrials.gov record NCT02536508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel-Group, 52-Week, Chronic-Dosing, Multi-Center Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Study identification
- NCT ID
- NCT02536508
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pearl Therapeutics, Inc.
- Industry
- Enrollment
- 627 participants
Conditions and interventions
Conditions
Interventions
- BGF MDI 320/14.4/9.6 μg Drug
- GFF MDI 14.4/9.6 μg Drug
- BFF MDI 320/9.6 μg Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2015
- Primary completion
- Sep 11, 2017
- Completion
- Sep 11, 2017
- Last update posted
- Feb 25, 2021
2015 – 2017
United States locations
- U.S. sites
- 64
- U.S. states
- 19
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Dothan | Alabama | 36303 | — |
| Research Site | Jasper | Alabama | 35501 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Gold River | California | 95670 | — |
| Research Site | Poway | California | 92064 | — |
| Research Site | Rolling Hills Estates | California | 90274 | — |
| Research Site | Sacramento | California | 95821 | — |
| Research Site | Clearwater | Florida | 33756 | — |
| Research Site | Miami | Florida | 33186 | — |
| Research Site | Ormond Beach | Florida | 32174 | — |
| Research Site | Pensacola | Florida | 32503 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Tampa | Florida | 33603 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Dacula | Georgia | 30019 | — |
| Research Site | Norcross | Georgia | 30071 | — |
| Research Site | Rincon | Georgia | 31326 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Minneapolis | Minnesota | 55402 | — |
| Research Site | Minneapolis | Minnesota | 55407 | — |
| Research Site | Woodbury | Minnesota | 55125 | — |
| Research Site | Saint Charles | Missouri | 63301 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Las Vegas | Nevada | 89106 | — |
| Research Site | Reno | Nevada | 89503 | — |
| Research Site | Albuquerque | New Mexico | 87108 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Gastonia | North Carolina | 28054 | — |
| Research Site | Greensboro | North Carolina | 27408 | — |
| Research Site | Hendersonville | North Carolina | 28739 | — |
| Research Site | Mooresville | North Carolina | 28117 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Cincinnati | Ohio | 45245 | — |
| Research Site | Columbus | Ohio | 43213 | — |
| Research Site | Columbus | Ohio | 43235 | — |
| Research Site | Dayton | Ohio | 45459 | — |
| Research Site | Dublin | Ohio | 43016 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Anderson | South Carolina | 29621 | — |
| Research Site | Charleston | South Carolina | 29406 | — |
| Research Site | Easley | South Carolina | 29640 | — |
| Research Site | Greenville | South Carolina | 29615 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Old Point Station | South Carolina | 29707 | — |
| Research Site | Rock Hill | South Carolina | 29732 | — |
| Research Site | Seneca | South Carolina | 29678 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Union | South Carolina | 29379 | — |
| Research Site | Johnson City | Tennessee | 37601 | — |
| Research Site | Kingwood | Texas | 77339 | — |
| Research Site | Longview | Texas | 75604 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Abingdon | Virginia | 24210 | — |
| Research Site | Newport News | Virginia | 23606 | — |
| Research Site | Richmond | Virginia | 23225 | — |
| Research Site | Richmond | Virginia | 23230 | — |
| Research Site | Tacoma | Washington | 98405 | — |
| Research Site | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02536508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02536508 live on ClinicalTrials.gov.